Regulation · on the rundown Tuesday, March 24, 2026
FDA flags alleged misleading claims on cancer drug
Covered by 2 outlets over 1 hour. First reported by seattletimes.com at 19:00 UTC on March 24, 2026.
- outlets2
- distinct reports2
- first to latest report1 h
- names in it1
What happened?
- MedPage Today reported that the FDA issued a warning Tuesday over alleged misleading statements by Patrick Soon-Shiong, MD.
- MedPage Today reported that Soon-Shiong is a biotech billionaire and owner of ImmunityBio.
- MedPage Today reported that Soon-Shiong recently told podcast listeners about his company's bladder cancer drug.
The FDA issued a warning Tuesday alleging that statements by Patrick Soon-Shiong, MD, owner of ImmunityBio, about his company's bladder cancer drug were misleading, MedPage Today reported.
A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Mar 24 19:00 | Report by seattletimes.com |
|
| Mar 24 19:35 | Report by MedPage Today |
|
The reports' titles are not shown here because they may name people in a sensitive matter; the links lead to each report.
Who was named?
- ImmunityBio
More news naming ImmunityBio
- Mar 25 · Healthcare ImmunityBio announces approval for ANKTIVA in Macau SAR, China 2
- Feb 18 · Biotech ImmunityBio shares rose after EU approved ANKTIVA for bladder cancer 3
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).